Skip to content
AnalystLens

International Flavors & Fragrances 8-K Report, Financial Results (Aug 4, 2026)

Reports
Earnings & Results·Other Events·Exhibits & Filings
Filing Date
Filed August 4, 2026
Period End
August 4, 2026
Security
IFF
In the record · 2016–202610-K1110-Q338-K151

IFF filed 11 annual reports (10-K), 33 quarterly reports (10-Q) and 151 current reports (8-K) between 2016 and 2026.

  1. Material agreement8-K · May ’17May ’17
  2. Material agreement8-K · Jan ’20Jan ’20
  3. Leadership change8-K · Feb ’22Feb ’22
  4. Leadership change8-K · Oct ’25Oct ’25

01—Abstract

Summary

Summary of the 8-K filed August 4, 2026. Cited figures are marked; the original filing is the authoritative source.

On August 4, 2026, International Flavors & Fragrances Inc. (IFF) reported second quarter 2026 results on a continuing operations basis, which excludes the Food Ingredients and Soy Crush, Concentrates, and Lecithin (SCL) businesses, now reported as discontinued operations.

Second quarter reported net sales were $1.95 billiona, up 2% versus the prior-year period, and currency neutral comparable sales rose 6%. Income from continuing operations before taxes was $64 million and reported EPS was $0.13 per diluted share, while adjusted EPS excluding amortization was $0.82. Adjusted operating EBITDA margin was 20.9% for the quarter on a continuing basis, compared with 19.7% including discontinued operations.

IFF agreed on May 29, 2026 to sell its Food Ingredients business to funds advised by CVC Capital Partners for net cash proceeds of approximately $3.8 billionb, subject to adjustments. IFF will retain an approximately 10% minority equity interest, and closing is expected by the end of the second quarter of 2027. The company expects to eliminate about $100 million of stranded corporate costs, with roughly two-thirds removed within the first year after closing and substantially all within two years.

IFF also introduced full-year 2026 guidance on a continuing operations basis, expecting sales of $7.4 billion to $7.6 billionc and adjusted operating EBITDA of $1.53 billion to $1.60 billion. It plans to reduce debt by over $1 billion from the proceeds and authorized a share repurchase program of $2.5 billion, including a $500 million accelerated share repurchase in the second half of 2026 and the remaining $2.0 billion after the divestiture closes, with completion targeted by the end of 2027.

02—Key points

Key Highlights

  1. Q2 2026 reported net sales of $1.95 billion, up 2% year over year; currency neutral comparable sales up 6%.
  2. Q2 2026 income from continuing operations before taxes of $64 million; reported EPS of $0.13 per diluted share; adjusted EPS ex amortization of $0.82.
  3. Q2 2026 adjusted operating EBITDA of $408 million on a continuing basis, with a 20.9% margin.
  4. Food Ingredients sale to CVC Capital Partners for net cash proceeds of approximately $3.8 billion, with IFF retaining a roughly 10% minority stake; closing expected by end of Q2 2027.
  5. Full-year 2026 continuing operations guidance: sales of $7.4 billion to $7.6 billion and adjusted operating EBITDA of $1.53 billion to $1.60 billion.
  6. Enhanced $2.5 billion share repurchase authorization, including a $500 million accelerated share repurchase in the second half of 2026.
  7. Plans to apply net divestiture proceeds to reduce debt by over $1 billion, targeting net debt to EBITDA leverage of 2.0x to 2.5x; net debt to credit adjusted EBITDA was 2.5x at quarter end.

03—Questions

Frequently Asked Questions

  1. What is the impact of the Food Ingredients divestiture on IFF's reported results?

    Food Ingredients and the SCL business are presented as discontinued operations for all periods shown, so results on a continuing basis cover Taste, Scent, and Health & Biosciences. Including discontinued operations, second quarter net sales were $2.78 billion and adjusted operating EBITDA was $548 million.

  2. How will IFF use the proceeds from the Food Ingredients sale?

    IFF plans to reduce outstanding debt by over $1 billion and fund a $2.5 billion share repurchase program. The repurchases include $500 million in the second half of 2026, with the remaining $2.0 billion expected after the transaction closes and completion targeted by the end of 2027.

  3. What cost savings does IFF expect after the divestiture?

    IFF identified approximately $100 million of corporate and functional stranded costs previously allocated to Food Ingredients. It expects to eliminate about two-thirds within the first year after closing and substantially all within two years.

  4. What is IFF's full-year 2026 outlook?

    For continuing operations, IFF expects 2026 sales of $7.4 billion to $7.6 billion and adjusted operating EBITDA of $1.53 billion to $1.60 billion. It expects comparable currency neutral sales growth of 2% to 4% and comparable currency neutral adjusted operating EBITDA growth of 4% to 8%.

  5. Which segments drove second quarter performance?

    On a comparable currency neutral basis, Scent sales rose 8%, Health & Biosciences rose 5%, and Taste rose 4%. Management attributed growth primarily to volume growth and productivity gains.

04—Continue

← View all 8-K filings